Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$98.83
-0.92%
Mkt Cap $19.93B
Analyst Ratings
Buy
14
Hold
5
Sell
0
Price Target (48 analysts)
$108.90
Range $84.00 – $135.00
Implied Upside
+10.2%
Consensus $108.90 vs current $98.83
NASDAQ·Healthcare·Biotechnology
$98.83
-0.92%
Mkt Cap $19.93B
Buy
14
Hold
5
Sell
0
Price Target (48 analysts)
$108.90
Range $84.00 – $135.00
+10.2%
Consensus $108.90 vs current $98.83